BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26634522)

  • 21. Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.
    Gao X; Liu W; Zhang X; Tang L; Wang L; Yan L; Yang H; Li T; Yang L; Ma N; Liu D
    Tumour Biol; 2016 Sep; 37(9):12103-12111. PubMed ID: 27209411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B.
    Seto WK; Wong DK; Kopaniszen M; Proitsi P; Sham PC; Hung IF; Fung J; Lai CL; Yuen MF
    Clin Infect Dis; 2013 Jun; 56(12):1695-703. PubMed ID: 23449268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population.
    Mbarek H; Ochi H; Urabe Y; Kumar V; Kubo M; Hosono N; Takahashi A; Kamatani Y; Miki D; Abe H; Tsunoda T; Kamatani N; Chayama K; Nakamura Y; Matsuda K
    Hum Mol Genet; 2011 Oct; 20(19):3884-92. PubMed ID: 21750111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study of two inflammation-related polymorphisms with susceptibility to hepatocellular carcinoma: a meta-analysis.
    Liu J; Xie B; Chen S; Jiang F; Meng W
    BMC Med Genet; 2014 Aug; 15():92. PubMed ID: 25108400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.
    Zhao X; Wang T; Liu B; Wu Z; Yu S; Wang T
    Tumour Biol; 2015 Apr; 36(4):2551-8. PubMed ID: 25480412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
    Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
    Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. +49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population.
    Gu X; Qi P; Zhou F; Ji Q; Wang H; Dou T; Zhao Y; Gao C
    Hum Immunol; 2010 Jan; 71(1):83-7. PubMed ID: 19778566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.
    Peng Q; Yang S; Lao X; Li R; Chen Z; Wang J; Qin X; Li S
    PLoS One; 2014; 9(12):e116026. PubMed ID: 25541958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis.
    Wei Y; Liu F; Li B; Chen X; Ma Y; Yan L; Wen T; Xu M; Wang W; Yang J
    Dig Dis Sci; 2011 Aug; 56(8):2227-36. PubMed ID: 21336601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
    Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
    World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients.
    Cheng HR; Liu CJ; Tseng TC; Su TH; Yang HI; Chen CJ; Kao JH
    PLoS One; 2013; 8(1):e53008. PubMed ID: 23326374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of leptin receptor (LEPR) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis B virus infection.
    Li Z; Yuan W; Ning S; Li J; Zhai W; Zhang S
    Mol Diagn Ther; 2012 Dec; 16(6):383-8. PubMed ID: 23090836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes.
    Jiang X; Ma Y; Cui W; Li MD
    Amino Acids; 2014 Aug; 46(8):1819-26. PubMed ID: 24846544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.
    Nishida N; Sawai H; Matsuura K; Sugiyama M; Ahn SH; Park JY; Hige S; Kang JH; Suzuki K; Kurosaki M; Asahina Y; Mochida S; Watanabe M; Tanaka E; Honda M; Kaneko S; Orito E; Itoh Y; Mita E; Tamori A; Murawaki Y; Hiasa Y; Sakaida I; Korenaga M; Hino K; Ide T; Kawashima M; Mawatari Y; Sageshima M; Ogasawara Y; Koike A; Izumi N; Han KH; Tanaka Y; Tokunaga K; Mizokami M
    PLoS One; 2012; 7(6):e39175. PubMed ID: 22737229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy.
    Hosaka T; Suzuki F; Kobayashi M; Fukushima T; Kawamura Y; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    Liver Int; 2015 Apr; 35(4):1290-302. PubMed ID: 25103089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance between HLA-DP gene rs2281388 polymorphism and hepatocellular carcinoma risk.
    Liu F; Wang J; Chang H; Lu J; Li H
    Int J Clin Exp Pathol; 2015; 8(6):7431-5. PubMed ID: 26261648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
    Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
    BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese.
    Wong DK; Watanabe T; Tanaka Y; Seto WK; Lee CK; Fung J; Lin CK; Huang FY; Lai CL; Yuen MF
    PLoS One; 2013; 8(6):e66920. PubMed ID: 23825586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.